Please assess the completion status of the following clinical trial:

Trial Title: Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Participants must be a single-organ recipient (kidney only)~* Participants who are receiving their first living donor or deceased donor transplant~Exclusion Criteria:~* Participants who are recipients of HLA-identical living-donor renal transplants~* Participants with a PRA value \> 10% within 30 days prior to the transplant~* Participants who have received a multi-organ transplant~* Participants who are who are positive for hepatitis C, hepatitis B surface antigen or HIV~* Participants who have received an investigational drug within 6 weeks of study entry~* Participants who have a previous history of, or who currently have, malignancies and/or lymphoma~* Participants who have received corticosteroids within three months of transplantation~* Participants who are 3rd transplant recipients~* Female participants who are pregnant or lactating. Fertile female participants who are sexually active must agree to use an acceptable method of birth control during the study

- Gender: ALL
- Minimum Age: 18 Months
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Campath 1-H (Type: EXPERIMENTAL): Campath 1-H

Based on this trial design, predict the completion outcome and termination type (if applicable).